@BiosensingIns

Biosensing Instrument supplies bio-analytical tools to accelerate drug discovery research

 Tempe, AZ
biosensingUSA.com
Joined January 2015
  • Tweets309
  • Following6
  • Followers50
210Media
Check out this paper from University of Missouri-Kansas City on "Exploring Multivalency in the Development of Anti-PD-L1 Peptides for Cancer Immunotherapy" Read it here: link.springer.com/article/10… #SPRm #DrugDiscovery #BindingAvidity

Exploring Multivalency in the Development of Anti-PD-L1 Peptides for Cancer Immunotherapy

Pharmaceutical Research - The PD-1/PD-L1 pathway is one of the most effective immune checkpoint pathways utilized for cancer immunotherapy. Despite the success of anti-PD-1/PD-L1 mAbs, there is...

link.springer.com
17
Eurofins Discover X will be hosting a Webinar on "Dissecting the Biology Behind Antibody-Drug Conjugates" on Thursday, Nov. 12. If you're interested in learning more about the applications of #SPRm in #DrugDiscovery come check it out! Register here: drugdiscoverynews.com/dissec…
27
Check out our latest application note on "Kinetic Analysis of NGF-Differentiated PC12 Neuronal Cells on an #SPRm Chip" Read it here: biosensingusa.com/applicatio… #DrugDiscovery #KineticAnalysis
11
Check out our latest Application Note on Label-Free Kinetic Analysis of Anti-TCR Binding to Jurkat T Cells Using #SPRm Read it here: biosensingusa.com/applicatio… #DrugDiscovery #BindingAnalysis
15
Biosensing Instrument will be at Discovery on Target 2026! Come see us at Booth #307 to say hi and learn more about our award winning #SPRm technology. Learn more about Discovery on Target 2026 here: discoveryontarget.com/ #BostonDOT #DrugDiscovery
12
Check out this paper from Yixian Wang at California State University, Los Angeles on accessing real-time interaction between antimicrobial liposomes and live Staphylococcus epidermidis using #SPRm Read it here: doi.org/10.1016/j.biosx.2026… #DrugDiscovery #BindingAnalysis
1
1
27
Check out our newest #SPRm Application Note on Agonist and Antagonist Peptide Binding Interaction Kinetics with GLP-1R! Read it here: biosensingusa.com/applicatio… #DrugDiscovery #BindingKinetics
1
27
Check out our latest AppNote on #SPR analysis of Malaria antigens! Read more: biosensingusa.com/applicatio… #DrugDiscovery #BindingAnalysis
18
Check out this paper on "Agonist and Antagonist Peptide Binding Interaction Kinetics" by our lovely team Miyuki Thirumurthy, Jesus Aguilar Diaz de leon, and Nguyen (Win) Ly, PhD as well as Shuchong Pan from Mayo Clinic Read it here: pubs.acs.org/doi/full/10.102…

In Vitro Characterization of Agonist and Antagonist Peptide Binding Interaction Kinetics to GLP-1R...

Abstract. The glucagon peptide 1 receptor (GLP-1R), a class-B-type G protein-coupled receptor (GPCR), is a key therapeutic target for many metabolic disord

pubs.acs.org
29
Check out this paper by Kris Borzilleri, Jonathan Brooks, and Felix Vajdos "Discovery of Potent and Brain-Penetrant Inverse Agonists for GPR61, an Orphan G Protein-Coupled Receptor"! Read it here: doi.org/10.1021/acs.jmedchem…

Discovery of Potent and Brain-Penetrant Inverse Agonists for GPR61, an Orphan G Protein-Coupled...

Abstract. GPR61 is a class A orphan G protein-coupled receptor (GPCR) that is predominantly expressed in the pituitary gland and appetite-regulating center

pubs.acs.org
59
Still wondering if our #SPRm is a good fit for you? These are just a few of the applications our newest SPRm 220 can do! Learn more on our website here: biosensingusa.com/products/i… #DrugDiscovery #BindingKinetics
10
Our newest Application Note on "Resolving Multiple Kinetic Binding Modes in Complex Biological Systems" is now available! Read it here: biosensingusa.com/applicatio… #SPRm #DrugDiscovery
17
Check out our latest #SPRm Application Note on Live-Cell Binding Analysis Targeting GLP-1R! Read it here: biosensingusa.com/applicatio… #BindingAnalysis #DrugDiscovery
15
Congratulations to the researchers at Jagiellonian University for their published paper with the first use of #SPRm to assess dual-activity interactions with the histamine H3 receptor ligands and MAO-B inhibitors. Read it here: mdpi.com/1422-0067/27/2/581 #DrugDiscovery

Rational Design, Synthesis and Pharmacological Evaluation of Chalcones as Dual-Acting Compounds—H...

Chalcone-based derivatives were designed as dual-acting ligands targeting the histamine H3 receptor (H3R) and monoamine oxidase B (MAO-B), based on the lead compound DL76. Three series of compounds...

mdpi.com
11
The #AACR Poster presented by our friends at Eurofins DiscoverX on "Integrated evaluation of payload-, Fc-, and target-mediated mechanisms of ADCs using streamlined complementary platforms" is now available for download! Read it here: biosensingusa.com/applicatio… #SPRm #DrugDiscovery

Application Note 177: Integrated evaluation of payload-, Fc-, and target-mediated mechanisms of...

The poster presented by Alpana Prasad of Eurofins DiscoverX during the AACR annual meeting 2026; now available for download. Authors: Alpana Prasad1, Surekh ...

biosensingusa.com
55
Thank you to Alpana Prasad and our friends at Eurofins DiscoverX for their poster presentation on "Integrated evaluation of payload-, Fc-, and target-mediated mechanisms of ADCs using streamlined complementary platforms" at the #AACR2026 annual meeting. #DrugDiscovery #SPRm
44
Biosensing Instrument will be at #BiophysicsDrugDiscovery next week! Come say hi to us at booth# 4 and learn more about #SPRm and check out our poster presentation as well! Learn more: biophysics-drugdiscovery.com…
🤖 Made with AI
12
Biosensing Instrument will have both a booth and a poster at #DrugDiscoveryChemistry and #BiophysicsDrugDiscovery this month. Learn more: drugdiscoverychemistry.com/ biophysics-drugdiscovery.com… #SPRm
10
Our newest AppNote on Two-Well #SPRMicroscopy is available to read now! Read it here: biosensingusa.com/applicatio… #DrugDiscovery #BindingKinetics
13
Alpana Prasad from Eurofins DiscoverX will be presenting a collaborative #SPRm poster on at the #AACR2026 annual meeting in San Diego on 4/22/2026. Learn more: aacr.org/meeting/aacr-annual… #DrugDiscovery #SPRm
61
Load more